Vorinostat Completed Phase 1 Trials for Cancer, Advanced Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00750178A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)
NCT01339871Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
NCT00106626Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors